Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis
Sherif H. Hassanien, Jonathon R. Bassman, Carmelita M. Perrien Naccarato, et al.
Drug Testing and Analysis (2020) Vol. 12, Iss. 8, pp. 1212-1221
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The anomalous pharmacology of fentanyl
Eamonn Kelly, Katy J. Sutcliffe, Damiana Cavallo, et al.
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 797-812
Closed Access | Times Cited: 93
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
Amanda L A Mohr, Barry K. Logan, Melissa F. Fogarty, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 6, pp. e116-e185
Open Access | Times Cited: 46
Fentanyl and its derivatives: Pain-killers or man-killers?
Jiří Patočka, Wenda Wu, Patrik Olekšák, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e28795-e28795
Open Access | Times Cited: 13
Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated
Neil B. Varshneya, Sherif H. Hassanien, Melissa C. Holt, et al.
Biochemical Pharmacology (2021) Vol. 195, pp. 114805-114805
Open Access | Times Cited: 44
Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide
Marthe M. Vandeputte, Meng-Hua M. Tsai, Li Chen, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 109939-109939
Closed Access | Times Cited: 22
Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression
Neil B. Varshneya, Sherif H. Hassanien, Melissa C. Holt, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 226, pp. 173572-173572
Open Access | Times Cited: 17
A quantitative LC-MS/MS analysis of Xylazine, p-Fluorofentanyl, Fentanyl and Fentanyl-Related compounds in postmortem blood
Michael T Truver, Sara C. Brogan, Emma A. Jaeschke, et al.
Journal of Chromatography B (2024) Vol. 1237, pp. 124059-124059
Closed Access | Times Cited: 6
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors
Amy J. Eshleman, Shanthi Nagarajan, Katherine M. Wolfrum, et al.
Biochemical Pharmacology (2020) Vol. 182, pp. 114293-114293
Closed Access | Times Cited: 41
Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids
David Vearrier, Oliver Grundmann
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 39
Endogenous opiates and behavior: 2020
Richard J. Bodnar
Peptides (2022) Vol. 151, pp. 170752-170752
Closed Access | Times Cited: 19
Evaluation of portable gas chromatography–mass spectrometry (GC–MS) for the analysis of fentanyl, fentanyl analogs, and other synthetic opioids
Pauline E. Leary, Koby L. Kizzire, Rebecca Chan Chao, et al.
Journal of Forensic Sciences (2023) Vol. 68, Iss. 5, pp. 1601-1614
Closed Access | Times Cited: 11
Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors
Neil B. Varshneya, D. Matthew Walentiny, L Moisă, et al.
Pharmacology Biochemistry and Behavior (2021) Vol. 208, pp. 173242-173242
Open Access | Times Cited: 26
Spectral trends in GC-EI-MS data obtained from the SWGDRUG mass spectral library and literature: A resource for the identification of unknown compounds
William P. Feeney, Arun S. Moorthy, Edward Sisco
Forensic Chemistry (2022) Vol. 31, pp. 100459-100459
Open Access | Times Cited: 16
In vitro functional assays as a tool to study new synthetic opioids at the μ-opioid receptor: Potential, pitfalls and progress
Marthe M. Vandeputte, Lakshmi Vasudevan, Christophe P. Stove
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108161-108161
Open Access | Times Cited: 15
Notes from the Field: Overdose Deaths Involving Para-fluorofentanyl — United States, July 2020–June 2021
Jessica Bitting, Julie O’Donnell, Christine L. Mattson
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 39, pp. 1239-1240
Open Access | Times Cited: 15
Toxicological Analysis of Fluorofentanyl Isomers in Postmortem Blood
Michael T Truver, Chris W. Chronister, Amy M Kinsey, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 8, pp. 835-843
Closed Access | Times Cited: 13
Para‐fluorofentanyl: Coincidence or intentional?
Jeremy R. Canfield, Kristin V. Canfield, Jon E. Sprague
Addiction (2024) Vol. 119, Iss. 9, pp. 1655-1656
Open Access | Times Cited: 2
Reinforcing effects of fentanyl analogs found in illicit drug markets
Alexander D. Maitland, Shelby A. McGriff, Grant C. Glatfelter, et al.
Psychopharmacology (2024) Vol. 241, Iss. 11, pp. 2375-2383
Open Access | Times Cited: 2
Fluorofentanyl and novel synthetic opioids in accidental overdose deaths
Jihau Yu, Katie Diekhans, Anson Tsang, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 8, pp. 573-581
Closed Access | Times Cited: 2
In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects
Anna Åstrand, Davide Guerrieri, Svante Vikingsson, et al.
Forensic Science International (2020) Vol. 317, pp. 110553-110553
Open Access | Times Cited: 15
Pharmacokinetics and pharmacodynamics of cyclopropylfentanyl in male rats
Marianne Skov‐Skov Bergh, Inger Lise Bogen, Nancy Garibay, et al.
Psychopharmacology (2021) Vol. 238, Iss. 12, pp. 3629-3641
Open Access | Times Cited: 11
Structurally diverse fentanyl analogs yield differential locomotor activities in mice
Neil B. Varshneya, D. Matthew Walentiny, David L. Stevens, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 222, pp. 173496-173496
Open Access | Times Cited: 8
Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development
Zoe Li, Ruili Huang, Menghang Xia, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2635-2635
Open Access | Times Cited: 1
Structure–Activity Relationships of the Fentanyl Scaffold: Identification of Antagonists as Potential Opioid Overdose Reversal Agents
Jessica P. Anand, Sierra C. Moore, Emma Dixon, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2830-2841
Open Access | Times Cited: 1
In vivo pharmacokinetic, pharmacodynamic and brain concentration comparison of fentanyl and para-fluorofentanyl in rats
Jeremy R. Canfield, Jon E. Sprague
Archives of Toxicology (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top